Mycophenolate Mofetil Hydrochloride Patent Expiration
Mycophenolate Mofetil Hydrochloride was first introduced by Roche Palo Alto Llc
Mycophenolate Mofetil Hydrochloride Patents
Given below is the list of patents protecting Mycophenolate Mofetil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cellcept | US5543408 | Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
Sep 15, 2013
(Expired) | Roche Palo |
Mycophenolate Mofetil Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Mycophenolate Mofetil Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Mycophenolate Mofetil Hydrochloride. The first generic version for Mycophenolate Mofetil Hydrochloride was by Endo Operations Ltd and was approved on Oct 28, 2016. And the latest generic version is by Bpi Labs Llc and was approved on Jun 1, 2023.
Given below is the list of companies who have filed for Mycophenolate Mofetil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Discontinued | INJECTION | N/A | Mar 5, 2021 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. BPI LABS
Bpi Labs Llc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Bpi Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Jun 1, 2023 |
Manufacturing Plant Locations New
Bpi Labs's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bpi Labs as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Oct 28, 2016 |
4. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Jan 15, 2021 |
5. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Mar 31, 2017 |
6. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Feb 28, 2017 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
7. STERISCIENCE SPECLTS
Steriscience Specialities Pte Ltd has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Steriscience Speclts.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Dec 23, 2022 |
8. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Mycophenolate Mofetil Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | injectable | Prescription | INJECTION | AP | Aug 31, 2017 |